The Role of CTX-II , Dyslipidemia ,Vitamin D in Polycystic Ovary Syndrome
DOI:
https://doi.org/10.37506/ijfmt.v14i4.11878Keywords:
CTX-II- Biomarkers- OA Osteoarthritis- Polycystic ovary syndrome- Dyslipidemia.Abstract
This study aimed to study the serum measurement of clinical value of type II collagen (CTX-II) in syndrome
of polycystic ovary in women and indicter as osteoarthritis disease marker analyzed in future levels with
a recent available immune enzyme-linked sorbent assay (ELISA) kit. For increasing sensitivity test, the
protocol was modified. Levels of CTX-II increased significantly as well total protein, while decrease vitamin
D and difference in lipid profile were practical between the patients compared with healthy women’s. The
obtained results suggested the monitoring interest of the serum CTX-II for the OA development in patients
of polycystic ovary syndrome in women and the relevance of the analysis of multiple time point for this
biomarker.
Downloads
Published
Issue
Section
License
https://creativecommons.org/licenses/by-nc/2.0/deed.en